Tamoxifen in breast cancer survivors with COVID 19: stop or go?

Cengiz Karaçin Pinar Karacin Yakup Ergün

Published in: Medical oncology (Northwood, London, England) (2021)

Keyphrases

coronavirus disease
sars cov
breast cancer cells
estrogen receptor
positive breast cancer
respiratory syndrome coronavirus